ROME and MILAN, Oct. 3, 2025 /PRNewswire/ -- The Department of Clinical and Molecular Medicine of Sapienza University of Rome (DMCM), Takis S.r.l. and Tethis S.p.A. today announce a joint initiative, to accelerate research on HER3-targeted therapies and advance the development of...
Hence then, the article about the department of clinical and molecular medicine of sapienza university of rome takis and tethis start a collaboration to advance her3 targeted therapies and diagnostics was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( The Department of Clinical and Molecular Medicine of Sapienza University of Rome, Takis and Tethis start a collaboration to advance HER3-targeted therapies and diagnostics )
Also on site :
- Suspected mountain lion attack in Colorado mountains under investigation
- Person falls to death on Boylston Street on New Year’s Eve
- Hazel Avenue in Orangevale closed as suspect barricades in home